Animation - Understanding NSCLC Treatment Options When You Have an EGFR Mutation
This animation provides an overview of EGFR mutations in non-small cell lung cancer (NSCLC) and different treatment options. The good news is that specific treatments can target EGFR mutations. If you have an EGFR mutation, you may be a candidate for targeted therapy, and there are many treatments that target EGFR. Watch to learn about tyrosine kinase inhibitors (TKIs), monoclonal antibody drugs, managing side effects, the importance of repeat biomarker testing, clinical trials, and more.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
Animation - Understanding NSCLC Treatment Options When You Have an EGFR Mutation
Slide Show - Understanding NSCLC Treatment When You Have an EGFR Mutation
1.
What is a gene mutation and how does it relate to lung cancer?
2.
How do doctors test for genetic mutations in lung cancer and why is it important?
3.
What is an EGFR mutation in lung cancer?
4.
How do doctors treat lung cancer with EGFR mutations?
5.
How did you find out you had EGFR-positive lung cancer?
6.
What was the comprehensive biomarker testing experience like?
7.
What has your treatment experience been for your EGFR-positive lung cancer?
